Table 1.

Demographic and Clinical Characteristics of Combined CBIT Trials by Treatment Group (N=232)

		CBIT n=117	PST n=115
		N (%)	N (%)
Gender	Male	79 (67.5%)	85 (73.9%)
	Female	38 (32.5%)	30 (26.1%)
Tic Medication Use	No Medication	64 (54.7%)	60 (52.2%)
	Tic Medication	37 (31.6%)	36 (31.3%)
	Other Medication	16 (13.7%)	19 (16.5%)
		Mean ± SD	Mean ± SD
Age		22.4 ±14.1	21.7 ± 14.2
Motor Tic Severity (YGTSS) at baseline		15.2 ± 4.0	14.8 ± 3.0
Vocal Tic Severity (YGTSS) at baseline		9.3 ± 4.9	8.7 ± 5.1
YGTSS-TTS		24.5 ± 6.5	23.4 ± 6.4
Impairment (YGTSS) at baseline		24.3 ± 8.4	23.6 ± 7.6

Positive Response ^(a) was defined by score of Much Improved or Very Much Improved on Clinical Global Impressions (CGI)-Improvement scae at 10 week.